Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Look at this!
Last days of the $2s IMO. It's likely that we won't see anything with a 2 in front of it again. If the stock wasn't so heavily manipulated, we would already be in the $3s today. We are losing ground again right now as they are taking us down at about the same time as yesterday. The first sucker punch came now and the second about 30-40 minutes before the market close. Good luck to all decent and patient longs who will prevail and do extremely well here. No other healthcare company has what Clover offers at any price. Counterpart Health alone is an unexpected blessing and probably worth a whole lot more than just any average healthcare company. All of those other companies with share prices between $11 and $550 a share. The majority are losing money on top of it. Go figure. Here we are sitting at $2.90 and its a struggle! lol Have a look at this healthcare company doing nothing special not profitable and without our Counterpart Health. SP is $12 and name is Alignment Healthcare Inc ticker (ALHC)
New post from CLOV. Shes ready to blow.
https://www.reddit.com/r/CLOV/comments/1ffujsu/new_cfo_linkedin_post_today/#lightbox
In the near future those who didn't load bigtime here will regret it! IMO $2.50 CLOV tickets will be worth ten times more. After that a meteoric rise in the long-term future is inevitable. The potential of Clover Health/Counterpart Health is massive. IMO Risk/Reward is HUGE at the moment! This one is now a no brainer! The wait is finally about over. GLTA
Totally normal, right? NOT! We're back to market manipulation. Short interest is about to learn a very hard lesson. Lots of major news ahead. HUGE gains in CLOV on the way. Just look at the competition's Share price. On top of it-Dinosaur companies that don't have anything like Counterpart Health to offer. They all need us. Clovers Counterpart Health is about to revolutionize Medicare advantage. The best part is, it works with all types of other healthcare companies. Do not underestimate what is about to take place here.
Evil and should be illegal hostage trading! A complete slap in the face to a REAL SHAREHOLDER who has done their DD and know what we own. Burn baby burn! It's coming bigtime and we will have the last laugh and satisfaction! Mark these words. Holding over 100K real live shares here and continue to add at these levels. Thanks, shorty, for the opportunity!
Today this was like watching paint dry while being held hostage by Mr. Shortie! What a disgrace!
GO CLOV! GO FAITHFUL INTELLIGENT AND ALL-KNOWING LONGS!
Humana cutting Medicare Advantage plans that cover 10% of members
The nation’s second largest MA insurer found that gaining members was costly.
Humana needs our Clover Health Counterpart Health to curb losses and become profitable. Great opportunity for Clover Health to add new members in our PPO no less. Will they be the next big announcement by Clover CEO Andrew? Never underestimate what is going to happen here! Longs know what we own and are adding and holding!
A slow choke hold going on here. Criminal and obvious but it continues. CLOV shareholders will have their $day $month $year! Payback is a B! Won't this turn into the best cash making machine? RIGHT? In the near future there will be many who wish they had backed up the truck here at these levels. I just crossed the 100K share level. I guess we should be thankful for the opportunity right here right now! GLTA real live CLOV longs! We know what we own who we are and what is really going on here!
Growth Mode Activated..... "This deal positions The Iowa Clinic as one of Counterpart's anchor customers in the Midwest, as Counterpart drives a broader strategic expansion across the country."
I’m actually hoping those who manipulate CLOV will push the price even lower. Many of you know I'm heavily vested in Clover Health, holding significant shares and options since my first buy in May 2021. It's been a wild ride, but the recent developments have been incredibly promising. Here’s why I’m embracing the possibility of CLOV being driven lower ahead of Q3:
Clover has already proven its concept with patented technology that stands out in the industry. The fact that larger insurers are facing challenges while we continue to improve demonstrates the competitive edge CLOV holds over established names in the Medicare Advantage space, such as Humana, UnitedHealth Group, and others. Humana has recently slashed profit projections due to unexpected rises in medical costs, while UnitedHealth Group has been dealing with legal battles over allegations of overbilling Medicare. These struggles highlight the growing pressures in the sector, yet Clover Health continues to show resilience and progress.
If the stock is pushed lower before our next earnings report and the update on our new SaaS revenue stream's profitability, it presents a strategic buying opportunity. Here’s a reminder of all CLOV has going for it following the last earnings report:
CLOV needs to hold the line here @$2.50 and starts the reversal process. I believe it would be explosive (short supplies of shares) once it starts- first passing the newer 2-year high and then onto $6.35...
Clover will be the next big three in Healthcare and Electronic Health Records.
.
https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.reddit.com%2Fr%2FHealthcare_Anon%2Fs%2F1dfeLsFDtU&data=05%7C02%7C%7C645129117a734488321a08dccc236f1d%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C638609699754792759%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=7fXMl9ei5jvUAhDZHRMrZjg4lAM2bn3nVWkACP8jQFc%3D&reserved=0
Ladies and gentlemen, we gather here today to reflect on a unique group of individuals: those who made the bold decision to short Clover Health stock. While their actions were driven by strategy, calculation, and perhaps a dash of skepticism, their journey became a testament to the unpredictable nature of markets and the complexities of betting against innovation.
These short-sellers embarked on their path with conviction, believing they had identified a weakness or a misstep in Clover Health’s trajectory. They combed through financials, analyzed market trends, and held firm in their belief that this company’s rise was unsustainable. In doing so, they played an essential role in keeping the market in balance, reminding us all that for every bull, there must be a bear.
But as time went on, and Clover Health showed resilience, adaptability, and growth, these short-sellers found themselves facing the harsh realities of a market that can often defy even the best-laid plans. What began as a calculated gamble became, for many, an expensive lesson in the power of innovation and perseverance. Clover Health didn’t falter the way they expected. Instead, it evolved, and with it, the fortunes of those betting against it changed.
In this reflection, we do not mourn their losses but celebrate their participation in the grand theater of the stock market, where risks are taken, lessons are learned, and the future remains unwritten. For every short-seller, there’s a story of ambition and belief, and today, we honor their place in that story.
May they find peace in the knowledge that in this dynamic, ever-shifting market, they played their part. And as Clover Health continues to rise, may we all remember the value of conviction – whether we stand with the bulls or the bears.
Rest easy, short-sellers. You gave it your all.
I've been tracking the MCR (Medical Cost Ratio) trends closely, and here's the latest update on projections for Q3 and Q4 of 2024. The guidance range has been adjusted to ensure that the full-year MCR stays within the 77%-79% target.
https://www.reddit.com/r/CLOV/comments/1ewrazv/mcr_2024_is_conservative_guidance_setting_up_for/
In my opinion adding here around $3 is an absolute no brainer. I have 40K shares average at 1.34. I am staring a new account now around $3 so that it won't average my other account up. To me $3 is the new bottom safe area. In the near future newcomers will be very happy to buy CLOV at $5 including Wall Street whales for their clients etc. Counterpart Health/Clover Health are going to be massive! I MEAN MASSIVE!
GOOD LUCK TO ALL CLOVER LONGS. THE FUN IS JUST BEGINNING!
CLOV finally its blast off time!
https://www.reddit.com/r/CLOV/comments/1etxtew/my_bullish_thesis_on_clover_health_why_the_market/
Absolutely. CLOV$ is about to announce some life changing news for the company, its stock, shareholders and the Board of Directors! Smart money has been loading CLOV big time for about 120 days now. Clovers Counterpart Health SaaS will be integrated into a massive amount of other healthcare providers platforms allowing them to be completely different and more profitable than ever thought possible. Licensing this SaaS will be much bigger and more profitable than the original Clover Healthcare would have ever been! We now have 2 companies.The $ potential is so big it's impossible to put a number on it at this moment. We will be doing that after we receive some of the details that we have been waiting for. Good luck all shareholders!
BURN SHORTY!
Will be interesting later this week….
CEO, Andrew Toy, and CFO, Peter Kuipers, will participate in a fireside chat presentation at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, 2024. Listen live at 2PM EST. Go the company's website to sign up and listen live!!!
I’m expecting possible Saas announcements/contracts at this conference, which will change the trajectory of this company and stock forever.
They teased it out on their previous earnings call and today’s early action, someone knows something.
Stay tuned for the fireworks.
CLOV everything to know!
https://www.youtube.com/live/7vELBeGYURA
CLOV short volume report.
https://fintel.io/ssv/us/clov
Maggots!
First of all CLOV is being heavily shorted today on lower volume. We have a wall at $1.91 which has been holding us down. In fact, they have taken us all the way back down now to where we opened. Can't wait until they get destroyed!
If you do simple math CLOV is more than 1000 basis points better than anyone else.
If clover can maintain even 500 basis points over competitors, the shared savings revenue model will net $100s of millions in revenue. From what I could find, the industry average cut for a SaaS provider in a shared savings model is 20%. I used that and an extremely conservative 5% to jam these numbers. I’m sure it’s not 100% correct, so feel free to cut all this numbers in half again…it’s still really impressive. That’s also not taking into account subscription revenue."
Watch this carefully. It will answer any and all questions.
https://www.youtube.com/live/Je2TdGUT8lc
$CLOV
CLOV Q 2...My main focus point is on MCR and insurance revenue growth year over year.
I strongly believe, and this is something Andrew mentioned on the earnings call, that Clov's ability to produce industry-leading MCR numbers for their direct insurance business, quarter over quarter, year over year, PROVES that their tech and platform WORKS.
Counterpart Health, formally Clover Assistant (CA), is the BIGGEST driving factor to Clovs industry-leading insurance MCR -- theirs is so low and IMPROVING each quarter, year over year compared to the rest of the industry
Machine learning compounds. the more data, the more time, the more inputs and closed-loop feedback, the faster and better the AI learns this is showing through THEIR OWN insurance members and business, that CA WORKs.
This is why I like clover so much. They are tech driven as a main focus. I honestly don’t think Clover is really worried about administering insurance as much as they used it to build their AI. It was a steppingstone. They obviously can keep using that however as their bread and butter, but now they have a real chance at pushing their software.
Legacy insurance is so far behind what counterpart assistant is doing it would take them 5-10 years to catch up in any meaningful way. Clover is there. The big names need to quit looking at clover as competition and start seeing them for what they are, a software / R&D / tech company. Insurance paid the bills and helped pave the way but the technology they have built is what will separate CLOV. They also hold the pertinent patents to their product so that gives them a bit of protection from being copied as well. GO CLOV$
Go CLOV!
https://www.youtube.com/live/Je2TdGUT8lc
Its breakout time!
Go CLOV! This is all a CLOV shareholder needs to know! Up we go and here is why! ENJOY!
https://www.youtube.com/live/Je2TdGUT8lc
Shorty is doing everything possible to keep the Friday $2 covered calls from happening! Mucho $$$$ either way for them. If we could get some news before Monday August 5th CLOV would run through $2. BIG BURN!
Schwaab, Fidelity and Vanguard all reported during the week that they added $CLOV to their funds. Great news for all of us CLOV LONGS!
$CLOV – New Charles Schwab fund invested $1 million USD in Clover Health. FNDA - Schwab Fundamental U.S. Small Company Index ETF filed a NPORT-P form on July 24, 2024. They owned 958,430 shares of Clover Health Investments Corp valued at $1,054,273 USD as of May 31, 2024.
$CLOV __ 18% INCREASE in Clover Health shares Last Quarter. Jupiter Asset Management Ltd filed a 13F-HR form on May 10, 2024. They owned 4,525,079 shares of Clover Health valued at $3,592,913 USD as of March 31, 2024. They had 3,832,201 shares on Dec 31, 2023.
A deep look at CLOV! Lots of great information. Looking really good!
https://www.youtube.com/live/oJs28Ir_vuk
$CLOV
Clovers' new spinoff company Counterpart Health and Counterpart assistant is now available to every doctor, hospital, medical provider in the world for a fee. They recently patented this after 4 years in the development stage. Within the last 3 weeks Clover has already signed up tens of thousands of medical providers nationwide. This system is a doctor's doctor of sorts that does most of the work for your doctor. It comes up with instant solutions/diagnoses that your doctor wouldn't have considered or thought of. Super smart and super profitable for Clover. We now have our hands and the potential to be in every doctor's office/hospital/healthcare provider in the world. As said before, within the last 3 weeks they have signed up tens of thousands of medical providers. More to be released the Q2 earnings report on August 2. Could be sooner.
https://investors.cloverhealth.com/news-releases/news-release-details/clover-health-announces-counterpart-health-new-saas-and-tech
60 Patents and Climbing
I periodically check this site for new patents. Since Clover's white paper on medication detection/adherence there have been 2 new patents listed.
Looks like they are doing everything they can to protect their software Clover Assistant.
Latest Patent release was on 5/14/2024 with another one right behind it on 4/30/2024
Toy mentioned more white papers so this is where I would expect to see something before a PR announcement.
These patents speak to something really bad ass and useful. This is huge for healthcare in general. CA Clover Assistant) truly is something great.
$CLOV
85% MCR (Medical Cost Ratio) is good. Clover is achieving 80% MCR due to Clover Assistant. A lot of cash can be saved when others adopt Counterpart Assistant SAAS (Software as a service). On $5B in revenue, CA (Chartered accounts) can save $250 M. The MA (Medicare Advantage) market size is over $430 Billion. Achieving 80% MCR vs 85% MCR saves $21.5 Billion. If Clover can capture 10% of this savings we are looking at 2.15 billion revenues, and a PE of 10 puts clover at 21.5 Billion market cap or $40 / share.
$CLOV
Healthcare investors are expecting the Republican presidential candidate to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Regulatory easing on Medicare Advantage could also rekindle talks on possible mergers between health insurers.
Under the current administration, the Centers for Medicare & Medicaid Services has hardened its stance on the program after it faced criticism for insurers overbilling the government and denying care to seniors too many times, the Wall Street Journal reported.
Republicans tend to favor privatizing government services and have been friendlier to Medicare Advantage plans, a trend that investors are betting could continue under a second Trump administration.
Also Read: UnitedHealth Analysts Boost Their Forecasts Following Upbeat Earnings
Regulatory easing on Medicare Advantage could also rekindle talks on possible mergers between health care providers.
$CLOV
Worth repeating! Adding some CLOV everyday at this level!
85% MCR is good. Clover is achieving 80% MCR due to Clover Assistant. A lot of cash can be saved when others adopt Counterpart Assistant SAAS. On 5 B in revenue, CA can save $250 M. The MA market size is over $430 Billion. Achieving 80% MCR vs 85% MCR saves $21.5 Billion. If Clover can capture 10% of this savings we are looking at 2.15 billion revenues, and a PE of 10 puts clover at 21.5 Billion market cap or $40 / share.
This will take some time but on the way to $40 a share will be tons of fun in itself! GLTA LONGS!
$CLOV